What they were paid
Keros Therapeutics Director Compensation Table · all 5 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $61,000 | $77,805 | $108,730 | $0 | $247,535 |
| FY2024 | $61,000 | — | $321,099 | — | $382,099 |
| FY2023 | $60,233 | — | $336,751 | — | $396,984 |
| FY2022 | $55,000 | — | $185,813 | — | $240,813 |
| FY2021 | $55,000 | — | $284,083 | — | $339,083 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Keros Therapeutics, Inc. DEF 14A filed April 22, 2026, accession 0001104659-26-046791, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Keros Therapeutics, Inc. filed document, accession 0001104659-26-046791. Every figure is read from that document and cited to the page and table it appears in. Filed April 22, 2026.
Get the Keros Therapeutics Board Governance Report
$247,535 Mary Ann Gray, FY2025 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 22, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025Keros Therapeutics pays directors a $41,500 cash retainer and $150,000 in equity.
Committees
FY2025 · as the proxy prints themAudit (Chair) · Compensation
The rest of the Keros Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Alpna Seth | Independent Director | $238,535 |
| Charles Newton | Independent Director | — |
| Jasbir Seehra | Director | — |
| Jean-Jacques Bienaimé | Chair of the Board | $259,443 |
| Julius Knowles | Independent Director | $239,035 |
| Nima Farzan | Independent Director | $239,035 |
The full Keros Therapeutics compensation record
free company briefThis page is one director within Keros Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the Keros Therapeutics proxy · each links to its own free briefOrder KROS
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.